MedPath

SODIUM THIOSULFATE INJECTION USP

SODIUM THIOSULFATE INJECTION USP

Approved
DIN Number

02428393

Drug Class

Human

Market Date

Nov 23, 2015

Company
HC

HOPE PHARMACEUTICALS LTD

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02428393
AIG Number0109248001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V03AB06 THIOSULPHATE
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification91:04.12
Health Canada Classification

ACTIVE INGREDIENTS (1)

SODIUM THIOSULFATEActive
Strength: 250 MG / ML
Monograph: SODIUM THIOSULFATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.